Update of a phase 1 study of intravenous CCI-779 given in combination with interferon-α to patients with advanced renal cell carcinoma.

被引：0
|
作者：
Smith, JW
Ko, YJ
Dutcher, J
Hudes, G
Escudier, B
Motzer, R
Négrier, S
Duclos, B
Galand, L
Strauss, L
机构：
[1] Providence Portland Med Ctr, Earle Chiles Res Inst, Portland, OR USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Our Lady Mercy Canc Ctr, Bronx, NY USA
[4] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[5] Inst Gustave Roussy, Villejuif, France
[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[7] Ctr Leon Berard, F-69373 Lyon, France
[8] CHU Hautepierre, F-67098 Strasbourg, France
[9] Wyeth Ayerst Res, Paris, France
[10] Wyeth Ayerst Res, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4513
引用
收藏
页码：385S / 385S
页数：1
相关论文
共 50 条
  • [21] A phase I/II study of nivolumab and axitinib in patients with advanced renal cell carcinoma.
    Zibelman, Matthew R.
    Carducci, Michael Anthony
    Ged, Yasser
    Molina, Ana M.
    Ravilla, Rahul
    Shaffer, David R.
    Lambert, Courtney
    Tafseer, Mahvish
    Basiura, Rachel
    Weismann, Danielle
    Kokate, Rutika
    Devarajan, Karthik
    Ruth, Karen
    Alpaugh, R. Katherine
    Anari, Fern
    Ghatalia, Pooja
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study
    Matsubara, Nobuaki
    Naito, Yoichi
    Nakano, Kenji
    Fujiwara, Yutaka
    Ikezawa, Hiroki
    Yusa, Wataru
    Namiki, Masayuki
    Okude, Takashi
    Takahashi, Shunji
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (11) : 922 - 928
  • [23] Interleukin-2, interferon-α and interleukin-2 plus interferon-α in renal cell carcinoma.: A randomized phase II trial
    Boccardo, F
    Rubagotti, A
    Canobbio, L
    Galligioni, E
    Sorio, R
    Lucenti, A
    Cognetti, F
    Ruggeri, E
    Landonio, G
    Baiocchi, C
    Besana, C
    Citterio, G
    De Rosa, M
    Calabresi, F
    TUMORI, 1998, 84 (05) : 534 - 539
  • [24] Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
    Yang, S.
    de Souza, P.
    Alemao, E.
    Purvis, J.
    BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1456 - 1460
  • [25] Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
    S Yang
    P de Souza
    E Alemao
    J Purvis
    British Journal of Cancer, 2010, 102 : 1456 - 1460
  • [26] Randomized 3-arm, phase 2 study of ternsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer.
    Carpenter, JT
    Roché, H
    Campone, M
    Colomer, R
    Jagiello-Gruszfeld, A
    Moore, L
    D'Amore, M
    Kong, S
    Boni, J
    Baselga, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 19S - 19S
  • [27] Pharmacogenomic expression profiling of renal cell carcinoma in a phase II trial of CCI-779: identification of surrogate markers of disease and predictors of outcome in the compartment of peripheral blood
    Burczynski, M
    Twine, N
    Stover, J
    Stadler, W
    Logan, T
    Marshall, B
    Dukart, G
    Trepicchio, W
    Dorner, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S51 - S51
  • [28] Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: a phase II study
    Padrik, P
    Leppik, K
    Arak, A
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 387 - 392
  • [29] Final phase II safety and efficacy results of study MC0452: Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma
    Merchan, J. R.
    Pitot, H. C.
    Qin, R.
    Liu, G.
    Fitch, T. R.
    Maples, W. J.
    Picus, J.
    Erlichman, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Phase II study of interferon-alpha (IFN), Gleevec or Iressa patients with metastatic renal cell carcinoma.
    Amato, R
    Kareidy, M
    Marsh, L
    Truong, L
    Shen, S
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9030S - 9030S
12345